Scattolin, ThomasTonon, GiovanniBotter, EleonoraCanale, Viviana ClaudiaHasanzadeh, MahdiCuscela, Denise MariaBuschini, Annamaria2024-05-192024-05-1920242050-750X2050-7518https://doi.org10.1039/d4tb00312hhttps://hdl.handle.net/20.500.12713/5771This review article explores the innovative field of eco-friendly cyclodextrin-based coordination polymers and metal-organic frameworks (MOFs) for transdermal drug delivery in the case of skin cancer therapy. We critically examine the significant advancements in developing these nanocarriers, with a focus on their unique properties such as biocompatibility, targeted drug release, and enhanced skin permeability. These attributes are instrumental in addressing the limitations inherent in traditional skin cancer treatments and represent a paradigm shift towards more effective and patient-friendly therapeutic approaches. Furthermore, we discuss the challenges faced in optimizing the synthesis process for large-scale production while ensuring environmental sustainability. The review also emphasizes the immense potential for clinical applications of these nanocarriers in skin cancer therapy, highlighting their role in facilitating targeted, controlled drug release which minimizes systemic side effects. Future clinical applications could see these nanocarriers being customized to individual patient profiles, potentially revolutionizing personalized medicine in oncology. With further research and clinical trials, these nanocarriers hold the promise of transforming the landscape of skin cancer treatment. With this study, we aim to provide a comprehensive overview of the current state of research in this field and outline future directions for advancing the development and clinical application of these innovative nanocarriers. This review article explores the innovative field of eco-friendly cyclodextrin-based coordination polymers and metal-organic frameworks (MOFs) for transdermal drug delivery in the case of skin cancer therapy.eninfo:eu-repo/semantics/closedAccessCd-MofGamma-CyclodextrinGreen ChemistryNanoparticlesInclusionEncapsulationComplexationDoxorubicinFabricationCopolymersReview Article12163807383938529820WOS:0011907604000012-s2.0-85191321370N/A10.1039/d4tb00312hQ1